A detailed history of Putnam Investments LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 17,055 shares of ALNY stock, worth $4.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,055
Holding current value
$4.13 Million
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$151.41 - $196.57 $2.58 Million - $3.35 Million
17,055 New
17,055 $3.26 Million
Q3 2022

Nov 14, 2022

BUY
$138.54 - $232.0 $6 Million - $10 Million
43,294 Added 149.81%
72,194 $14.5 Million
Q2 2022

Aug 15, 2022

BUY
$120.42 - $169.29 $3.48 Million - $4.89 Million
28,900 New
28,900 $4.22 Million
Q2 2021

Aug 16, 2021

SELL
$128.63 - $176.89 $10.6 Million - $14.6 Million
-82,300 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$126.83 - $175.69 $10.4 Million - $14.5 Million
82,300 New
82,300 $11.6 Million
Q3 2020

Nov 16, 2020

SELL
$121.19 - $165.49 $3.34 Million - $4.56 Million
-27,541 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$104.21 - $156.44 $2.87 Million - $4.31 Million
27,541 New
27,541 $4.08 Million
Q3 2019

Nov 14, 2019

SELL
$70.9 - $87.82 $5.71 Million - $7.07 Million
-80,500 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$65.86 - $92.79 $5.3 Million - $7.47 Million
80,500 New
80,500 $5.84 Million
Q3 2018

Nov 14, 2018

SELL
$87.52 - $122.67 $1.11 Million - $1.55 Million
-12,660 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$88.31 - $107.8 $1.12 Million - $1.36 Million
12,660 New
12,660 $1.25 Million
Q4 2017

Feb 14, 2018

SELL
$114.49 - $139.98 $15.4 Million - $18.8 Million
-134,572 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$72.53 - $118.27 $9.76 Million - $15.9 Million
134,572
134,572 $15.8 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.8B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.